Wells Fargo & Company Sellas Life Sciences Group, Inc. Transaction History

Wells Fargo & Company

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.51 - $1.55 $8,188 - $24,886	-16,056 Reduced 98.16%	301 $0
Q4 2023 Feb 09, 2024	BUY	$0.88 - $1.57 $35 - $62	40 Added 0.25%	16,357 $17,000
Q3 2023 Nov 13, 2023	BUY	$1.42 - $1.83 $4 - $5	3 Added 0.02%	16,317 $26,000
Q2 2023 Aug 15, 2023	BUY	$1.35 - $1.8 $232 - $309	172 Added 1.07%	16,314 $25,000
Q1 2023 May 12, 2023	BUY	$1.18 - $3.86 $2 - $7	2 Added 0.01%	16,142 $23,000
Q4 2022 Feb 13, 2023	BUY	$1.8 - $5.41 $9,007 - $27,071	5,004 Added 44.94%	16,140 $38,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.38 $2 - $3	-1 Reduced 0.01%	11,136 $22,000
Q2 2022 Aug 12, 2022	BUY	$2.14 - $4.15 $10,783 - $20,911	5,039 Added 82.63%	11,137 $25,000
Q1 2022 May 16, 2022	SELL	$4.73 - $7.18 $2,421 - $3,676	-512 Reduced 7.75%	6,098 $41,000
Q4 2021 Feb 14, 2022	BUY	$5.36 - $9.53 $13,400 - $23,825	2,500 Added 60.83%	6,610 $37,000
Q3 2021 Nov 15, 2021	SELL	$8.21 - $10.53 $22,528 - $28,894	-2,744 Reduced 40.04%	4,110 $37,000
Q2 2021 Aug 16, 2021	BUY	$7.19 - $13.71 $136 - $260	19 Added 0.28%	6,854 $76,000
Q1 2021 May 13, 2021	BUY	$5.5 - $11.71 $37,290 - $79,393	6,780 Added 12327.27%	6,835 $58,000
Q3 2020 Nov 05, 2020	BUY	$1.88 - $3.58 $18 - $35	10 Added 22.22%	55 $0
Q2 2020 Aug 13, 2020	BUY	$1.53 - $3.93 $10 - $27	7 Added 18.42%	45 $0
Q1 2020 May 14, 2020	BUY	$1.7 - $4.08 $64 - $155	38 New	38 $0

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $21M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.